Browsing Tag
60 Degrees Pharmaceuticals
3 posts
60 Degrees Pharmaceuticals eyes FDA approval pathway for tafenoquine in babesiosis treatment
60 Degrees Pharmaceuticals targets FDA approval for tafenoquine in babesiosis as January 2027 trial results approach. Explore the risks.
Telehealth distribution becomes central to 60 Degrees Pharmaceuticals’ malaria prevention execution plan
60 Degrees Pharmaceuticals partners with Runway Health to expand ARAKODA access. Explore what this telehealth shift means for growth and execution.
Could this malaria drug become a breakthrough babesiosis cure? Yale and 60 Degrees aim to find out
Find out how 60 Degrees Pharmaceuticals and Yale are working to develop tafenoquine as a treatment for babesiosis, a rising tick-borne disease threat.